Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ABD 3001

Next Previous
Drug Profile

ABD 3001

Alternative Names: ABD-3001; DIMATE

Latest Information Update: 05 Nov 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Advanced BioDesign
  • Class Antineoplastics; Small molecules
  • Mechanism of Action Aldehyde dehydrogenase inhibitors; Apoptosis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Acute myeloid leukaemia; Myelodysplastic syndromes
  • No development reported Breast cancer; Malignant melanoma; Non-small cell lung cancer; Osteosarcoma

Most Recent Events

  • 28 Oct 2024 Phase-II clinical trials in Acute myeloid leukaemia (Second-line therapy or greater) in France (IV) (NCT05601726)
  • 28 Oct 2024 Phase-II clinical trials in Myelodysplastic syndromes (Second-line therapy or greater) in France (IV) (NCT05601726)
  • 28 Oct 2024 French health authorities approve compassionate use of ABD 3001 for one patient with Acute myeloid leukaemia

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top